Discontinuation report EVICEL
| Report ID | 203717 |
| Drug Identification Number | 02348497 |
| Brand name | EVICEL |
| Common or Proper name | THROMBIN FIBRINOGEN |
| Company Name | OMRIX BIOPHARMACEUTICALS LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | THROMBIN FIBRINOGEN |
| Strength(s) | 1200UNIT 90MG |
| Dosage form(s) | KIT SOLUTION |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | Vial |
| ATC code | B02BC |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-06-06 |
| Remaining supply date | 2023-09-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | MDA BLOOD BANK, SHEBA HOSPITAL, RAMAT-GAN KIRYAT ONO, TEL-AVIV ISRAEL 5510801 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-09-06 | French | Compare |
| v1 | 2023-09-06 | English | Compare |
Showing 1 to 2 of 2